MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
Rockwell Medical DIO Ratio 2011-2025 | RMTI
Annual DIO Ratio Rockwell Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28.5 | 26.3 | 22.7 | 24 | 22.8 | 22.7 | 52 | 95.2 | 61.9 | 31.3 | 22.4 | 22.4 | 21.1 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 95.2 | 21.1 | 34.9 |
Quarterly DIO Ratio Rockwell Medical
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27.1 | 33.4 | - | 24.3 | 25.6 | 27.8 | - | 23.9 | 30.5 | 30.5 | - | 26 | 28.8 | 25.9 | - | 24.3 | 26.1 | 24.3 | - | 23.9 | 23.8 | 23.4 | - | 21.6 | 23.6 | 24.1 | - | 25.1 | 19.5 | 34 | - | 51.4 | 59.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 59.3 | 19.5 | 28.3 |
DIO Ratio of other stocks in the Drug manufacturers industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
58.7 | - | - | $ 142 M |  USA |
 |
Aerie Pharmaceuticals
AERI
|
459 | - | - | $ 754 M | USA |
 |
Canopy Growth Corporation
CGC
|
167 | $ 1.13 | -2.4 % | $ 122 M |  Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
133 | - | 7.5 % | $ 6.35 M | USA |
 |
Cronos Group
CRON
|
221 | $ 2.63 | - | $ 1.38 B | Canada |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
48.9 | - | 0.86 % | $ 117 M | USA |
 |
Catalent
CTLT
|
71.9 | - | - | $ 11.5 B | USA |
 |
Agile Therapeutics
AGRX
|
82.7 | - | 10.11 % | $ 58.2 M | USA |
 |
DURECT Corporation
DRRX
|
460 | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
149 | - | -39.89 % | $ 27.7 M | USA |
 |
Aurora Cannabis
ACB
|
1.35 K | $ 4.21 | -1.17 % | $ 86.3 M | Canada |
 |
Endo International plc
ENDP
|
100 | - | - | $ 28.9 M |  Irlanda |
 |
Zomedica Corp.
ZOM
|
183 | - | -0.21 % | $ 98 M | USA |
 |
Evoke Pharma
EVOK
|
995 | - | - | $ 36.6 M | USA |
 |
HEXO Corp.
HEXO
|
703 | - | 2.45 % | $ 38.1 M | Canada |
 |
Emergent BioSolutions
EBS
|
176 | $ 12.47 | 2.55 % | $ 638 M | USA |
 |
Athenex
ATNX
|
158 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
366 | $ 21.54 | - | $ 2.05 B |  France |
 |
OrganiGram Holdings
OGI
|
2.83 K | $ 1.68 | -1.18 % | $ 402 M | Canada |
 |
Organogenesis Holdings
ORGO
|
85.9 | $ 5.17 | -0.29 % | $ 681 M | USA |
 |
Evolus
EOLS
|
50.3 | $ 6.7 | 0.45 % | $ 416 M | USA |
 |
Harrow Health
HROW
|
80.1 | $ 50.17 | 0.3 % | $ 1.64 B | USA |
 |
China Pharma Holdings
CPHI
|
168 | $ 1.24 | -7.14 % | $ 21.7 M |  China |
 |
Sonoma Pharmaceuticals
SNOA
|
117 | $ 3.53 | -2.41 % | $ 4.38 M | USA |
 |
Bausch Health Companies
BHC
|
172 | $ 7.0 | 0.07 % | $ 2.55 B | Canada |
 |
Lannett Company
LCI
|
127 | - | 1.15 % | $ 7.11 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
239 | $ 3.92 | -1.01 % | $ 55.1 M | USA |
 |
Pacira BioSciences
PCRX
|
246 | $ 26.12 | 0.19 % | $ 1.21 B | USA |
 |
PetIQ
PETQ
|
64.9 | - | 1.64 % | $ 400 M | USA |
 |
Jupiter Wellness
JUPW
|
59.7 | - | - | $ 33.6 M | USA |
 |
Perrigo Company plc
PRGO
|
143 | $ 13.99 | 0.36 % | $ 1.92 B | USA |
 |
ProPhase Labs
PRPH
|
30.1 | $ 0.44 | -2.49 % | $ 6.97 M | USA |
 |
Veru
VERU
|
179 | $ 2.17 | - | $ 293 M | USA |
 |
Radius Health
RDUS
|
204 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
49.1 | - | -4.76 % | $ 65.3 M | USA |
 |
cbdMD
YCBD
|
165 | $ 1.39 | 1.84 % | $ 5.99 M | USA |
 |
OptiNose
OPTN
|
370 | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
347 | $ 8.86 | -3.68 % | $ 629 M | USA |
 |
PLx Pharma
PLXP
|
97.2 | - | -27.8 % | $ 2.56 M | USA |
 |
Tilray
TLRY
|
170 | $ 9.02 | -0.06 % | $ 5.57 B | Canada |
 |
TherapeuticsMD
TXMD
|
1.04 K | $ 1.65 | 0.79 % | $ 17.2 M | USA |